Bovie Medical Current Ratio 2006-2020 | APYX

Bovie Medical current ratio from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Bovie Medical Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.07B $0.01B 7.00
2019-12-31 $0.08B $0.01B 6.23
2019-09-30 $0.08B $0.01B 8.73
2019-06-30 $0.08B $0.01B 10.38
2019-03-31 $0.09B $0.01B 11.40
2018-12-31 $0.09B $0.01B 10.43
2018-09-30 $0.11B $0.02B 4.93
2018-06-30 $0.02B $0.01B 3.56
2018-03-31 $0.02B $0.01B 3.82
2017-12-31 $0.02B $0.01B 3.78
2017-09-30 $0.02B $0.01B 4.63
2017-06-30 $0.02B $0.01B 4.29
2017-03-31 $0.03B $0.01B 5.00
2016-12-31 $0.03B $0.01B 5.03
2016-09-30 $0.02B $0.00B 4.85
2016-06-30 $0.02B $0.01B 4.46
2016-03-31 $0.02B $0.01B 2.85
2015-12-31 $0.02B $0.00B 5.35
2015-09-30 $0.02B $0.01B 5.08
2015-06-30 $0.03B $0.00B 6.38
2015-03-31 $0.03B $0.00B 6.15
2014-12-31 $0.02B $0.00B 4.08
2014-09-30 $0.02B $0.00B 5.25
2014-06-30 $0.02B $0.00B 7.13
2014-03-31 $0.02B $0.00B 8.00
2013-12-31 $0.02B $0.00B 6.81
2013-09-30 $0.02B $0.00B 4.59
2013-06-30 $0.02B $0.01B 2.40
2013-03-31 $0.02B $0.00B 7.10
2012-12-31 $0.02B $0.00B 8.45
2012-09-30 $0.02B $0.00B 8.47
2012-06-30 $0.02B $0.00B 8.23
2012-03-31 $0.02B $0.00B 8.15
2011-12-31 $0.02B $0.00B 6.90
2011-09-30 $0.02B $0.00B 8.39
2011-06-30 $0.02B $0.00B 8.19
2011-03-31 $0.02B $0.00B 7.35
2010-12-31 $0.02B $0.00B 8.26
2010-09-30 $0.02B $0.00B 6.70
2010-06-30 $0.02B $0.00B 7.41
2010-03-31 $0.01B $0.00B 4.79
2009-12-31 $0.01B $0.00B 5.34
2009-09-30 $0.01B $0.00B 4.27
2009-06-30 $0.01B $0.00B 3.90
2009-03-31 $0.01B $0.00B 4.83
2008-12-31 $0.01B $0.00B 5.44
2008-09-30 $0.01B $0.01B 2.40
2008-06-30 $0.01B $0.00B 5.48
2008-03-31 $0.01B $0.00B 5.28
2007-12-31 $0.01B $0.00B 6.88
2007-09-30 $0.01B $0.00B 5.63
2007-06-30 $0.01B $0.00B 5.20
2007-03-31 $0.01B $0.00B 4.72
2006-12-31 $0.01B $0.00B 4.72
2006-09-30 $0.01B $0.00B 4.73
2006-06-30 $0.01B $0.00B 4.65
2006-03-31 $0.01B $0.00B 4.10
2005-12-31 $0.01B $0.00B 4.01
2005-09-30 $0.01B $0.00B 4.17
2005-06-30 $0.01B $0.00B 4.02
2005-03-31 $0.01B $0.00B 4.23
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.152B $0.028B
Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $160.540B 27.84
Medtronic (MDT) Ireland $128.656B 20.92
Stryker (SYK) United States $71.825B 23.31
Boston Scientific (BSX) United States $51.972B 24.43
Baxter (BAX) United States $43.843B 26.76
Lonza Group Ag (LZAGY) Switzerland $35.618B 0.00
Terumo (TRUMY) Japan $28.824B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.260B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.490B 16.67
ResMed (RMD) United States $22.237B 35.09
Smith & Nephew SNATS (SNN) United Kingdom $17.941B 0.00
Sunny Optical Technology (SNPTF) China $14.851B 0.00
Bio-Rad Laboratories (BIO) United States $13.955B 63.53
Insulet (PODD) United States $11.256B 1115.19
Perrigo (PRGO) Ireland $7.569B 13.54
Shandong Weigao Medical Polymer (SHWGF) China $7.281B 0.00
Canopy Growth (CGC) Canada $6.981B 0.00
Quidel (QDEL) United States $6.614B 51.98
GN STORE NORD (GNNDY) Denmark $6.590B 34.05
Hill-Rom Holdings (HRC) United States $6.576B 18.54
William Demant Holdings (WILYY) Denmark $6.552B 0.00
Haemonetics (HAE) United States $5.498B 33.02
ICU Medical (ICUI) United States $4.106B 29.95
GW Pharmaceuticals (GWPH) United Kingdom $3.911B 0.00
Neogen (NEOG) United States $3.835B 64.96
Agios Pharmaceuticals (AGIO) United States $3.654B 0.00
Envista Holdings (NVST) United States $3.387B 0.00
NuVasive (NUVA) United States $3.256B 26.15
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.660B 0.00
National Vision Holdings (EYE) United States $2.289B 39.60
TG Therapeutics (TGTX) United States $2.262B 0.00
AtriCure (ATRC) United States $1.987B 0.00
Aurora Cannabis (ACB) Canada $1.552B 0.00
Cardiovascular Systems (CSII) United States $1.373B 0.00
MacroGenics (MGNX) United States $1.137B 0.00
Aphria (APHA) Canada $1.120B 0.00
NanoString Technologies (NSTG) United States $1.111B 0.00
Phibro Animal Health (PAHC) United States $1.070B 21.33
Cerus (CERS) United States $0.976B 0.00
PetIQ (PETQ) United States $0.873B 25.20
InMode (INMD) Israel $0.851B 17.99
OraSure Technologies (OSUR) United States $0.846B 170.38
Omeros (OMER) United States $0.830B 0.00
VAREX IMAGING (VREX) United States $0.769B 19.09
Quanterix (QTRX) United States $0.757B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.756B 127.92
Eagle Pharmaceuticals (EGRX) United States $0.731B 52.36
Zynex (ZYXI) United States $0.612B 61.50
Meridian Bioscience (VIVO) United States $0.599B 22.57
LeMaitre Vascular (LMAT) United States $0.552B 31.44
Lantheus Holdings (LNTH) United States $0.549B 11.05
Surmodics (SRDX) United States $0.532B 64.15
Vapotherm (VAPO) United States $0.530B 0.00
Owens & Minor (OMI) United States $0.486B 12.87
Repro-Med Systems (KRMD) United States $0.377B 316.67
Utah Medical Products (UTMD) United States $0.352B 25.59
Cytosorbents (CTSO) United States $0.352B 0.00
BioLife Solutions (BLFS) United States $0.331B 147.09
Viemed Healthcare (VMD) United States $0.309B 27.69
Organigram Holdings (OGI) Canada $0.297B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.294B 0.00
HEXO (HEXO) $0.276B 0.00
Female Health (VERU) United States $0.241B 0.00
InfuSystems Holdings (INFU) United States $0.221B 122.22
Chimerix (CMRX) United States $0.218B 0.00
Evolus (EOLS) United States $0.174B 0.00
Chembio Diagnostics (CEMI) United States $0.172B 0.00
Exagen (XGN) United States $0.157B 0.00
Fonar (FONR) United States $0.149B 13.24
Rockwell Medical (RMTI) United States $0.148B 0.00
MTech Acquisition (KERN) United States $0.137B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Surface Oncology (SURF) United States $0.133B 0.00
Liberty Health Sciences (LHSIF) Canada $0.132B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.121B 0.00
Brainsway (BWAY) Israel $0.085B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.076B 0.00
Wound Management Technologies (SMTI) United States $0.076B 0.00
United-Guardian (UG) United States $0.073B 16.93
Nephros (NEPH) United States $0.068B 0.00
Capricor Therapeutics (CAPR) United States $0.068B 0.00
GUARDION HEALTH (GHSI) United States $0.043B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
ImmuCell (ICCC) United States $0.030B 0.00
NF Energy Saving (BIMI) China $0.026B 0.00
FSD PHARMA INC (HUGE) Canada $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Myomo (MYO) United States $0.011B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00